Streetbeat News

Equity Actions

PLSE

Pulse Biosciences announced preliminary results for its rights offering, expected to generate $60M in immediate gross proceeds. The offering received subscriptions exceeding $83M, with allocations to be proportionately distributed among over-subscribed rights holders. The company expects to receive $60M in gross proceeds, with potential additional proceeds from warrant exercises.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:05 pm

EYEN

Eyenovia has announced the pricing of a $5 million registered direct offering. The combined offering price for each share of common stock and accompanying warrant is set at $0.66.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:03 pm

EYEN

Eyenovia has announced a $5 million registered direct offering of 7,575,757 shares and accompanying warrants at a price of $0.66 per share.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:02 pm

AMWL

American Well shares are trading lower after the company announced a 1-for-20 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:58 am

NXL

Nexalin Technology shares are trading lower following the announcement of a $5.25 million public offering of 3 million shares at $1.75 per share.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:49 am

ASST

Asset Entities (ASST) has announced a 1-for-5 reverse stock split in an effort to regain compliance with Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:15 am

MNMD

MindMed (MNMD) will be included in the Russell 2000 and Russell 3000 indexes, effective today. This inclusion is likely to increase the stock's visibility and attract more institutional investors.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:13 am

ELYM

Eliem Therapeutics has been added to the Russell 2000 and Russell 3000 indexes, effective today.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:12 am

LL

LL Flooring Holdings is reportedly in financial distress, having hired a consultant with restructuring capabilities. F9 Investments criticizes the current board's leadership and calls for urgent changes to save the company.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:09 am

AMWL

Amwell's board has approved a 1-for-20 reverse stock split of its common stock, which is expected to become effective on July 10, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:05 am